Identification of a subset of patients with acute myeloid leukemia characterized by long-term in vitro proliferation and altered cell cycle regulation of the leukemic cells

Bibliography

• Dohner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010;115:453-74
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114:937-51
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research N. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013;368:2059-74
   PubMed Web of Science ®Google Scholar
• Irish JM, Hovland R, Krutzik PO, et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 2004;118:217-28
   PubMed Web of Science ®Google Scholar
• Grimwade D, Hills RK. Independent prognostic factors for AML outcome. Hematology Am Soc Hematol Educ Program 2009;2009:385-95
   Google Scholar
• Bruserud O, Gjertsen BT, Foss B, et al. New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of aml cells – the present use in experimental studies and the possible importance for future therapeutic approaches. Stem Cells 2001;19:1-11
   PubMed Web of Science ®Google Scholar
• Horton SJ, Huntly BJ. Recent advances in acute myeloid leukemia stem cell biology. Haematologica 2012;97:966-74
   PubMed Web of Science ®Google Scholar
• Mayani H, Flores-Figueroa E, Chavez-Gonzalez A. In vitro biology of human myeloid leukemia. Leuk Res 2009;33:624-37
   PubMed Web of Science ®Google Scholar
• van Gosliga D, Schepers H, Rizo A, et al. Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells. Exp Hematol 2007;35:1538-49
   PubMed Web of Science ®Google Scholar
• Ailles LE, Gerhard B, Hogge DE. Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines. Blood 1997;90:2555-64
   PubMed Web of Science ®Google Scholar
• Bruserud O, Hovland R, Wergeland L, et al. Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities. Haematologica 2003;88:416-28
   PubMed Web of Science ®Google Scholar
• Hatfield KJ, Hovland R, Oyan AM, et al. Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels. Leukemia 2008;22:287-93
   PubMed Web of Science ®Google Scholar
• Mosevoll KA, Akkok CA, Hervig T, et al. Stem cell mobilization and harvesting by leukapheresis alters systemic cytokine levels in patients with multiple myeloma. Cytotherapy 2013;15:850-60
   PubMed Web of Science ®Google Scholar
• Reikvam H, Tamburini J, Skrede S, et al. Antileukaemic effect of PI3K-mTOR inhibitors in acute myeloid leukaemia-gene expression profiles reveal CDC25B expression as determinate of pharmacological effect. Br J Haematol 2014;164:200-11
   PubMed Web of Science ®Google Scholar
• Stavrum AK, Petersen K, Jonassen I, et al. Analysis of gene-expression data using J-Express. Curr Protoc Bioinformatics 2008;Chapter 7:Unit 7 3
   PubMedGoogle Scholar
• Ryningen A, Stapnes C, Bruserud O. Clonogenic acute myelogenous leukemia cells are heterogeneous with regard to regulation of differentiation and effect of epigenetic pharmacological targeting. Leuk Res 2007;31:1303-13
   PubMed Web of Science ®Google Scholar
• Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-7
   PubMed Web of Science ®Google Scholar
• van Rhenen A, Feller N, Kelder A, et al. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival. Clin Cancer Res 2005;11:6520-7
   PubMed Web of Science ®Google Scholar
• Blair A, Hogge DE, Sutherland HJ. Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR. Blood 1998;92:4325-35
   PubMed Web of Science ®Google Scholar
• Murohashi I, Tohda S, Suzuki T, et al. Autocrine growth mechanisms of the progenitors of blast cells in acute myeloblastic leukemia. Blood 1989;74:35-41
   PubMed Web of Science ®Google Scholar
• Padro T, Ruiz S, Bieker R, et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000;95:2637-44
   PubMed Web of Science ®Google Scholar
• Shih TT, Hou HA, Liu CY, et al. Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survival. Blood 2009;113:3161-7
   PubMed Web of Science ®Google Scholar
• Maxwell CA, Keats JJ, Crainie M, et al. RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability. Mol Biol Cell 2003;14:2262-76
   PubMed Web of Science ®Google Scholar
• Meraldi P, Sorger PK. A dual role for Bub1 in the spindle checkpoint and chromosome congression. EMBO J 2005;24:1621-33
   PubMed Web of Science ®Google Scholar
• Raemaekers T, Ribbeck K, Beaudouin J, et al. NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization. J Cell Biol 2003;162:1017-29
   PubMed Web of Science ®Google Scholar
• Ribbeck K, Groen AC, Santarella R, et al. NuSAP, a mitotic RanGTP target that stabilizes and cross-links microtubules. Mol Biol Cell 2006;17:2646-60
   PubMed Web of Science ®Google Scholar
• Lens SM, Voest EE, Medema RH. Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat Rev Cancer 2010;10:825-41
   Google Scholar
• D’Angiolella V, Esencay M, Pagano M. A cyclin without cyclin-dependent kinases: cyclin F controls genome stability through ubiquitin-mediated proteolysis. Trends Cell Biol 2013;23:135-40
   PubMed Web of Science ®Google Scholar
• Koffa MD, Casanova CM, Santarella R, et al. HURP is part of a Ran-dependent complex involved in spindle formation. Current Biol 2006;16:743-54
   PubMed Web of Science ®Google Scholar
• Khadka DB, Cho WJ. Topoisomerase inhibitors as anticancer agents: a patent update. Expert opin Ther pat 2013;23:1033-56
   PubMed Web of Science ®Google Scholar
• Majka J, Burgers PM. The PCNA-RFC families of DNA clamps and clamp loaders. Prog Nucleic Acid Res Mol Biol 2004;78:227-60
   PubMed Web of Science ®Google Scholar
• Petit MM, Schoenmakers EF, Huysmans C, et al. LHFP, a novel translocation partner gene of HMGIC in a lipoma, is a member of a new family of LHFP-like genes. Genomics 1999;57:438-41
   PubMed Web of Science ®Google Scholar
• Hartsink-Segers SA, Zwaan CM, Exalto C, et al. Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target. Leukemia 2013;27:560-8
   PubMed Web of Science ®Google Scholar
• Ikezoe T, Yang J, Nishioka C, et al. A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia. Mol Cancer Ther 2007;6:1851-7
   PubMed Web of Science ®Google Scholar
• Lin SF, Lin PM, Yang MC, et al. Expression of hBUB1 in acute myeloid leukemia. Leuk Lymphoma 2002;43:385-91
   PubMed Web of Science ®Google Scholar
• Snauwaert S, Vanhee S, Goetgeluk G, et al. RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia. Haematologica 2012;97:1539-47
   Google Scholar
• Tsykunova G, Reikvam H, Ahmed AB, et al. Targeting of polo-like kinases and their cross talk with Aurora kinases – possible therapeutic strategies in human acute myeloid leukemia? Expert Opin Investig Drugs 2012;21:587-603
   PubMed Web of Science ®Google Scholar
• Tzankov A, Strasser U, Dirnhofer S, et al. In situ RHAMM protein expression in acute myeloid leukemia blasts suggests poor overall survival. Ann Hematol 2011;90:901-9
   PubMed Web of Science ®Google Scholar
• Wadia PP, Coram M, Armstrong RJ, et al. Antibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation. Blood 2010;115:2077-87
   PubMed Web of Science ®Google Scholar
• Chen CC, Gau JP, You JY, et al. Prognostic significance of beta-catenin and topoisomerase IIalpha in de novo acute myeloid leukemia. Am J Hematol 2009;84:87-92
   PubMed Web of Science ®Google Scholar
• Wang YH, Takanashi M, Tsuji K, et al. Level of DNA topoisomerase IIalpha mRNA predicts the treatment response of relapsed acute leukemic patients. Leuk Res 2009;33:902-7
   PubMed Web of Science ®Google Scholar
• Lockwood WW, Thu KL, Lin L, et al. Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinoma. Clin Cancer Res 2012;18:1936-46
   PubMed Web of Science ®Google Scholar
• Ricke RM, van Deursen JM. Aurora B hyperactivation by Bub1 overexpression promotes chromosome missegregation. Cell cycle 2011;10:3645-51
   PubMed Web of Science ®Google Scholar
• Liao W, Liu W, Yuan Q, et al. Silencing of DLGAP5 by siRNA significantly inhibits the proliferation and invasion of hepatocellular carcinoma cells. PLoS ONE 2013;8:e80789
   Web of Science ®Google Scholar
• Gudmundsson KO, Thorsteinsson L, Sigurjonsson OE, et al. Gene expression analysis of hematopoietic progenitor cells identifies Dlg7 as a potential stem cell gene. Stem Cells 2007;25:1498-506
   PubMed Web of Science ®Google Scholar
• Cohen Y, Gutwein O, Garach-Jehoshua O, et al. The proliferation arrest of primary tumor cells out-of-niche is associated with widespread downregulation of mitotic and transcriptional genes. Hematology 2014;19(5):286-92
   PubMed Web of Science ®Google Scholar
• Lee YP, Wong CH, Chan KS, et al. In vivo FRET imaging revealed a regulatory role of RanGTP in kinetochore-microtubule attachments via Aurora B kinase. PLoS One 2012;7:e45836
   Web of Science ®Google Scholar
• Arnaoutov A, Dasso M. The Ran GTPase regulates kinetochore function. Dev Cell 2003;5:99-111
   PubMed Web of Science ®Google Scholar
• Doan PL, Chute JP. The vascular niche: home for normal and malignant hematopoietic stem cells. Leukemia 2012;26:54-62
   PubMed Web of Science ®Google Scholar
• Foss B, Nesthus I, Bergheim J, et al. Serum levels of thrombopoietin and stem cell factor in acute leukemia patients with chemotherapy-induced cytopenia and complicating infections. Platelets 1999;10:17-23
   PubMed Web of Science ®Google Scholar
• Lyman SD, Jacobsen SE. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 1998;91:1101-34
   PubMed Web of Science ®Google Scholar
• Gibson FM, Scopes J, Daly S, et al. IL-3 is produced by normal stroma in long-term bone marrow cultures. Br J Haematol 1995;90:518-25
   PubMed Web of Science ®Google Scholar
• Taussig DC, Vargaftig J, Miraki-Moud F, et al. Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction. Blood 2010;115:1976-84
   PubMed Web of Science ®Google Scholar
• Hatfield K, Ryningen A, Corbascio M, et al. Microvascular endothelial cells increase proliferation and inhibit apoptosis of native human acute myelogenous leukemia blasts. Int J Cancer 2006;119:2313-21
   PubMed Web of Science ®Google Scholar
• Ninomiya M, Abe A, Katsumi A, et al. Homing, proliferation and survival sites of human leukemia cells in vivo in immunodeficient mice. Leukemia 2007;21:136-42
   PubMed Web of Science ®Google Scholar
• Schuurhuis GJ, Meel MH, Wouters F, et al. Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells. PLoS One 2013;8:e78897
   PubMed Web of Science ®Google Scholar
• Motorin D, Bakken A, Foss Abrahamsen J, et al. Characterization of clonogenic progenitors in autologous peripheral blood stem cell grafts: evaluation of a simple in vitro assay suitable for routine clinical use. Hematology (Am Soc Hematol Educ Program) 2003;8:313-18
   Google Scholar
• Ohler L, Geissler K. Semi-solid colony growth in acute myeloid leukemia and its relation to cytogenetic risk groups. Leuk Lymphoma 2002;43:1743-7
   PubMed Web of Science ®Google Scholar
• Schnerch D, Yalcintepe J, Schmidts A, et al. Cell cycle control in acute myeloid leukemia. Am J Cancer Res 2012;2:508-28
   PubMed Web of Science ®Google Scholar
• Uemura N, Nakanishi Y, Kato H, et al. Antibody-based proteomics for esophageal cancer: identification of proteins in the nuclear factor-kappaB pathway and mitotic checkpoint. Cancer Sci 2009;100:1612-22
   PubMed Web of Science ®Google Scholar
• Kuo TC, Lu HP, Chao CC. The tyrosine kinase inhibitor sorafenib sensitizes hepatocellular carcinoma cells to taxol by suppressing the HURP protein. Biochem Pharmacol 2011;82:184-94
   PubMed Web of Science ®Google Scholar
• Yang J, Splittgerber R, Yull FE, et al. Conditional ablation of Ikkb inhibits melanoma tumor development in mice. J Clin Invest 2010;120:2563-74
   Google Scholar
• Guzman ML, Li X, Corbett CA, et al. Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8). Blood 2007;110:4436-44
   PubMed Web of Science ®Google Scholar
• Koch HB, Zhang R, Verdoodt B, et al. Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. Cell cycle 2007;6:205-17
   PubMed Web of Science ®Google Scholar
• Bruserud O, Ryningen A, Olsnes AM, et al. Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells. Haematologica 2007;92:332-41
   PubMed Web of Science ®Google Scholar
• Kentsis A, Reed C, Rice KL, et al. Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia. Nat Med 2012;18:1118-22
   PubMed Web of Science ®Google Scholar
• Bruserud O, Aasen I, Akselsen PE, et al. Interleukin 1 receptor antagonist (IL1RA) in acute leukaemia: IL1RA is both secreted spontaneously by myelogenous leukaemia blasts and is a part of the acute phase reaction in patients with chemotherapy-induced leucopenia. Eur J Haematol 1996;57:87-95
   PubMed Web of Science ®Google Scholar
• Estrov Z, Kurzrock R, Estey E, et al. Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors. Blood 1992;79:1938-45
   PubMed Web of Science ®Google Scholar
• Stosic-Grujicic S, Basara N, Milenkovic P, et al. Modulation of acute myeloblastic leukemia (AML) cell proliferation and blast colony formation by antisense oligomer for IL-1 beta converting enzyme (ICE) and IL-1 receptor antagonist (IL-1ra). J Chemother 1995;7:67-70
   PubMed Web of Science ®Google Scholar
• Ortiz LA, Dutreil M, Fattman C, et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 2007;104:11002-7
   PubMed Web of Science ®Google Scholar
• Weimar IS, Miranda N, Muller EJ, et al. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+). Exp Hematol 1998;26:885-94
   PubMed Web of Science ®Google Scholar
• Kastrinaki MC, Pavlaki K, Batsali AK, et al. Mesenchymal stem cells in immune-mediated bone marrow failure syndromes. Clin Develop Immunol 2013;2013:265608
   PubMedGoogle Scholar
• Lowenberg B, van Putten WL, Touw IP, et al. Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. N Engl J Med 1993;328:614-19
   PubMed Web of Science ®Google Scholar
• Barreyro L, Will B, Bartholdy B, et al. Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS. Blood 2012;120:1290-8
   PubMed Web of Science ®Google Scholar
• Kim JG, Sohn SK, Kim DH, et al. Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia. Leuk Lymphoma 2005;46:885-91
   PubMed Web of Science ®Google Scholar
• Verstovsek S, Kantarjian H, Estey E, et al. Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome. Leukemia 2001;15:1165-70
   PubMed Web of Science ®Google Scholar